Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome

Arayo Haga1, Tatsuyoshi Funasaka, Yasufumi Niinaka

  • 1Department of Hygienics, Gifu Pharmaceutical University, Gifu, Japan. arayo@gifu-pu.ac.jp

Insights

Autocrine motility factor (AMF) promotes tumor cell survival by inhibiting apoptosis, a key mechanism in cancer drug resistance. Targeting AMF signaling may restore cancer cell death and improve chemotherapy efficacy.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Immunology

Background:

  • Autocrine motility factor (AMF) is a cytokine linked to tumor malignancy and rheumatoid arthritis.
  • AMF signaling is implicated in tumor cell locomotion, metastasis, and resistance to apoptosis.
  • High AMF secretion correlates with resistance to drug-induced apoptosis in human fibrosarcoma cells.

Purpose of the Study:

  • To investigate the role of AMF in anti-apoptotic activity and its impact on cancer chemotherapy.
  • To explore the molecular mechanisms by which AMF confers resistance to apoptosis.
  • To evaluate the therapeutic potential of targeting AMF signaling against cancer.

Main Methods:

  • Utilized human fibrosarcoma HT-1080 cell lines with high AMF secretion.
  • Analyzed gene expression of apoptotic protease activating factor-1 (Apaf-1) and Caspase-9.
  • Employed cellular signaling inhibitors (PKC, PI3K, MAPK) and antibodies against AMF.
  • Tested efficacy in murine ascites Ehrlich tumor models.

Main Results:

  • AMF signaling induced anti-apoptotic activity in HT-1080 cells, which lacked Apaf-1 and Caspase-9 expression.
  • Inhibitors restored Apaf-1 and Caspase-9 gene expression and favored apoptosis in response to anti-cancer drugs.
  • Antibodies against AMF induced apoptosis in vitro and enhanced anti-cancer drug efficacy in vivo.
  • AMF appears to regulate Apaf-1 and Caspase-9 gene expression, indirectly affecting apoptosome formation.

Conclusions:

  • AMF plays a critical role in conferring apoptotic resistance to tumor cells, enabling survival under stress and chemotherapy.
  • Targeting AMF signaling pathways presents a novel therapeutic strategy to overcome cancer drug resistance.
  • Understanding AMF-mediated apoptosis evasion is crucial for developing more effective cancer treatments.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.